B

BGM Group Ltd.

BGM Nasdaq Healthcare · Pharmaceutical Preparations Chengdu, China www.bgmgroupltd.com
$8.84
Mkt Cap 1.77B

Holding company operating a Chinese pharmaceutical business through contractual arrangements with a subsidiary in China.

From the annual report

Our Holding Company Structure and Contractual Arrangements BGM Group Ltd is not a Chinese operating company but a Cayman Islands holding company with its business operations conducted by Gansu Qilianshan Pharmaceutical Co., Ltd. (the VIE , Gansu QLS ) and its subsidiaries established in the PRC. BGM Group Ltd (formerly known as Qilian International Holding Group Limited) is a Cayman Islands exempted company with limited liability incorporated on February 7, 2019. Qilian International (Hong Kong) Holdings Limited., which we refer to as Qilian HK , our wholly-owned subsidiary, was incorporated in Hong Kong on January 30, 2019. Qilian HK’s wholly owned subsidiary, Qilian International Trading (Chengdu) Co., Ltd., formerly known as Chengdu Qilian Trading Co., Ltd., which we refer to as WFOE , was organized pursuant to PRC laws on May 15, 2019. Gansu Qilianshan Pharmaceutical Co. Ltd., which we refer to as Gansu QLS, the VIE, was established in August 30, 2006, as a result of restructuring from Gansu State-operated Qilianshan Pharmaceutical Factory, which was incorporated in July 1969 in Jiuquan, Gansu Province, PRC pursuant to PRC laws. Gansu QLS’ shareholders include certain PRC residents and corporate entities controlled by PRC residents. 55 Table of Contents Pursuant to PRC laws, each entity formed under PRC law shall have certain business scope approved by the Administration of Industry and Commerce or its local counterpart.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…